Menu
Aims and Scope
Infusion Journal, the official publication of the National Home Infusion Association, is the premier source for impactful, relevant, and innovative professional and scientific content related to infusion medications in health care. It contains peer-reviewed scientific manuscripts on infusion medication therapy.
Ethical Policies
Infusion Journal is committed to maintaining the highest standards of publication ethics and to supporting ethical research practices following the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE). It adheres to the COPE Code of Conduct for Journal Publishers, the COPE Code of Conduct for Journal Editors, and the COPE Ethical Guidelines for Peer Reviewers.
Authorship
Infusion Journal follows the ICMJE recommendations that authorship be based on the following 4 criteria:
In addition to being accountable for the parts of the work done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.
All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work.
Plagiarism
To detect and prevent plagiarism, manuscripts submitted to Infusion Journal may be screened with anti-plagiarism software. Any manuscript may be screened, especially if there is reason to suppose part or all of the text has been previously published.
Disclosures and Conflict of Interest
Any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated should be disclosed during the submission process through the electronic manuscript submission form.
Peer Review
All submissions to Infusion Journal are first reviewed internally by one or more of the journal editors. At this stage, manuscripts may be rejected without peer review if it is determined that they are not relevant to the journal.
Manuscripts that are determined as relevant are sent out for peer review to one or more independent reviewers. Based on the feedback from these reviewers and the editors’ judgment, a decision is given on the manuscript. Authors will typically be notified of acceptance, non-acceptance, or need for revision within 6–8 weeks of submission.
Infusion Journal adheres to a policy of blind reviewing, in which the identity of the author is, as far as possible, kept from reviewers, while reviewers’ names are kept confidential.
Human Rights and Informed Consent
For manuscripts reporting medical studies involving human participants, it is suggested that authors provide a statement identifying the ethics committee that approved the study, and that the study conforms to recognized standards. These standards encourage authors to conduct studies in a way that ensures adequate steps have been taken to minimize harm to participants, to avoid coercion or exploitation, to protect confidentiality, and to minimize the risk of physical and psychological harm. ICMJE suggests non-essential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained.
AI Policy
Recommendation for Authors
Natural language processing tools driven by artificial intelligence (AI) do not qualify as authors, and Infusion Journal will screen for them in author lists. The use of AI (for example, to help generate content or images, write code, process data, or for translation) should be disclosed in the Methods or Acknowledgments section of manuscripts.
Recommendation for Peer Reviewers
Infusion Journal does not support the use of AI or large language models (LLMs) as a substitute for human expertise in the review process. The journal follows the Committee on Publication Ethics (COPE). You may wish to read their guidelines for reviewers at https://publicationethics.org/sites/default/files/ethical-guidelines-peer-reviewers-cope.pdf.
Maintaining confidentiality both throughout and following the review process is important, so please do not share information about your assigned manuscripts, their content, or your review with any person or entity, including LLMs and AI tools.
Corrections, Retractions and Editorial Expressions of Concern
Infusion Journal will issue corrections, retraction statements, errata, and other post-publication updates.
Author Correction: An Author Correction may be published to correct an important error(s) made by the author(s) that affects the scientific integrity of the published article, the publication record, or the reputation of the authors or the journal.
Publisher Correction: A Publisher Correction may be published to correct an important error(s) made by the journal that affects the scientific integrity of the published article, the publication record, or the reputation of the authors or of the journal.
Addendum: An addendum is generally published when significant additional information crucial to the reader’s understanding of the article has come to light following publication of the article.
Editorial Expression of Concern: An Editorial Expression of Concern is a statement from the editors alerting readers to serious concerns affecting the integrity of the published paper. EEoCs are published online and are bidirectionally linked to the published paper. They receive a DOI and are indexed in major scholarly databases such as PubMed. EEoCs may be an interim measure or may be final.
Retraction: An article may be retracted when the integrity of the published work is substantially undermined owing to errors in the conduct, analysis and/or reporting of the study. Violation of publication or research ethics may also result in a study’s retraction. The original article is marked as retracted but a PDF version remains available to readers, and the retraction statement is bi-directionally linked to the original published paper. Retraction statements will typically include a statement of assent or dissent from the authors.
When making corrections to articles, in the majority of cases the original article (PDF and HTML) is corrected and is bi-directionally linked to and from the published amendment notice, which details the original error. For the sake of transparency, when changes made to the original article affect data in figures, tables or text (for example, when data points/error bars change or curves require redrawing) the amendment notice will reproduce the original data.
Removal of published content
In exceptional circumstances, Infusion Journal reserves the right to remove an article or other content from Infusion Journal’s online platforms. Such action may be taken when
(i) Infusion Journal has been advised that content is defamatory, infringes a third party’s intellectual property right, right to privacy, or other legal right, or is otherwise unlawful;
(ii) a court or government order has been issued, or is likely to be issued, requiring removal of such content;
(iii) content, if acted upon, would pose an immediate and serious risk to health. Removal may be temporary or permanent. Bibliographic metadata (e.g. title and authors) will be retained, and will be accompanied by a statement explaining why the content has been removed.
The home setting for infusion medications offers an ample supply of topics for interesting and unique patient cases to report. If you have a patient case or idea for writing a case report or questions about submitting a manuscript to Infusion Journal, contact: infusionjournal@nhia.org.
Learn more about the journal and review information on manuscript submission.
Infusion Journal is supported by:
